-
FDA Decision Sends Pain Therapeutics Reeling
Monday, August 6, 2018 - 3:32pm | 427Read More...Pain Therapeutics, Inc. (NASDAQ: PTIE) plunged 47.7 percent Monday after receiving a Complete Response Letter from the Food and Drug Administration for Remoxy’s New Drug Application. What Happened The FDA rejected Pain’s lead asset and said the drug’s negatives outweigh its...
-
Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates
Wednesday, August 1, 2018 - 7:38am | 1657Read More...Biotech stocks had a fairly decent run up in July after a nearly flat performance in June. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) is up about 5 percent. As the earnings season kicks into high gear and amid several other catalysts, August is likely to be an action-packed...
-
Pain Therapeutics Shares Double On Clinical Study Data
Tuesday, January 9, 2018 - 12:56pm | 494Read More...Shares of Pain Therapeutics, Inc. (NASDAQ: PTIE) soared higher by more than 150 percent Tuesday after the company announced encouraging results from a study involving its late-stage drug candidate, REMOXY. What You Need To Know Pain Therapeutics said that REMOXY, a drug candidate intended to be...
-
Pain Therapeutics Gains 7%, FDA Has Accepted Company's Remoxy For Review
Wednesday, April 13, 2016 - 11:32am | 179Read More...Shares of Pain Therapeutics, Inc. (NASDAQ: PTIE), a micro-cap biopharmaceutical company whose lead drug candidate, REMOXY, is used for the treatment of moderate to severe pain. Pain Therapeutics announced after Tuesday's market close the U.S. Food and Drug Administration determined that its...
-
Cantor Analyst: Durect Is Worth $3/Share, So Buy It
Wednesday, June 24, 2015 - 1:53pm | 297Read More...In a report issued Tuesday, Cantor Fitzgerald analyst Irina Rivkind Koffler reiterated a Buy rating and $3.00 price target on shares of DURECT Corporation (NASDAQ: DRRX), a micro-cap specialty pharmaceutical company. The firm likes the company in account of its “attractive post-operative...
-
Top Percentage Gainers and Losers as of 2pm 6/24/11
Friday, June 24, 2011 - 2:03pm | 911Read More...Best 1) Southern Union (NYSE: SUG): Shares of Southern Union are currently trading up 16.4% from yesterday's close to $39.76. The company has received an acquisition proposal from The Williams Companies (NYSE: WMB) for $39 per share in cash. The deal is valued at 8.7 billion. Southern Union...
-
Top Percentage Gainers and Losers as of 12:15pm 6/24/11
Friday, June 24, 2011 - 12:17pm | 738Read More...Best 1) Southern Union (NYSE: SUG): Shares of Southern Union are currently trading up 16.9% from yesterday's close to $39.93. The company has received an acquisition proposal from The Williams Companies (NYSE: WMB) for $39 per share in cash. The deal is valued at 8.7 billion. Southern Union...
